PCM
KYTX icon

Prelude Capital Management’s Kyverna Therapeutics KYTX Stock Holding History

Prelude Capital Management’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$111K Sell
36,247
-31,299
-46% -$96.1K 0.01% 894
2025
Q1 		$130K Buy
67,546
+23,784
+54% +$45.9K 0.01% 925
2024
Q4 		$164K Buy
43,762
+22,367
+105% +$83.7K 0.01% 906
2024
Q3 		$105K Buy
+21,395
New +$105K 0.01% 1045